• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OSL 0.00% 0.6¢

ONCOSIL MEDICAL LTD - Corporate Spotlight

OncoSil Medical Ltd is an Australia-based medical device company focused on localized... OncoSil Medical Ltd is an Australia-based medical device company focused on localized treatments for patients with unresectable locally advanced pancreatic cancer (LAPC). The Company is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The Company has developed a cancer treatment device, the OncoSil brachytherapy device, which is a critical component of a brachytherapy treatment for locally advanced unresectable pancreatic cancer. The OncoSil device delivers a targeted intratumoral placement of Phosphorous-32 (32P) in the treatment of locally advanced unresectable pancreatic cancer. The OncoSil device has received a device designation in the European Union, United Kingdom and United States for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy.More

No Corporate Spotlight currently available.

(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $19.99M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $1.536K 256K

Buyers (Bids)

No. Vol. Price($)
6 2871929 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 19743778 22
View Market Depth
Last trade - 10.06am 03/07/2024 (20 minute delay) ?
Last
0.6¢
  Change
0.000 ( 10.0 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 623500
Last updated 11.25am 03/07/2024 ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.